CBD may offer a host of benefits including relief from pain, anxiety, and even acne, but not all products are created equally. Geocann, maker of CBD-infused edibles, tinctures, topicals, and other products set themselves apart by focusing on maximizing the efficiency of CBD absorption by the body.
Many consumers are likely unaware of just how little of the CBD they ingest is actually absorbed by the body. Geocann may have just provided a solution to the absorption conundrum. The company has released new soft gels utilizing its patented VESIsorb system to deliver CBD to the body.
“The formulation is loaded with a science-backed two-to-one ratio of CBD to BCP (beta-caryophyllene) which has been shown to have a synergistic effect as agonists for the CB2, 5-HT1A, and glycine receptors,” a Geocann spokesperson said through a press release.
Jesse Lopez, chief executive officer, and founder of Geocann feels the VESIsorb system could mean big things for Geocann and the CBD industry as a whole.
“This product launch signifies substantial first-to-market milestones for the cannabis industry and further advances Geocann’s leadership position to combine clinically-researched cannabinoids with technologically-advanced innovations that differentiate our formulations with superior therapeutic performance and unmatched supporting science,” Lopez said.
Biodeliverability is a bit of a hot issue for scientists and researchers analyzing CBD. So much of the CBD consumers ingest is not absorbed by the body. Different products and methods can increase the rate of absorption, but unfortunately, pills and soft gels are often considered to have a lower rate of absorption when compared to tinctures or vaporizing. However, new consumers already accustomed to taking pills and soft gels may be more comfortable with this method of ingestion, making the VESIsorb delivery system a great option.
“It is well-known that hemp oil is poorly absorbed in the body,” said Marc Weder, chief scientific officer for Geocann. “Formulations utilizing VESIsorb ensure that health-conscious consumers receive the maximum benefits from key cannabinoids and terpenes, like CBD and BCP. Better absorption leads to higher plasma concentration levels and allows the body to use more of these active ingredients.”
Geocann will try to take full advantage of its patent and is using the VESIsorb delivery system and soft gels to expand its market reach. The patent may make the company appealing to distributors around the world and its products are now available in other countries including Germany.
“We are proud to be the first to deliver a precise and consistent solid dosage form of CBD formulated in a patented delivery system with a 30-year history of safe and effective use. As the consumer demand for bio-enhanced cannabinoid products continues to grow, Geocann is supremely positioned to be the industry’s premier choice for the safest and most efficacious product solutions,” said Lopez.
